Understanding Metabolic Regulation and Its Influence on Cell Physiology

Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: .
Molecular cell (Impact Factor: 14.02). 02/2013; 49(3):388-98. DOI: 10.1016/j.molcel.2013.01.018
Source: PubMed


Metabolism impacts all cellular functions and plays a fundamental role in biology. In the last century, our knowledge of metabolic pathway architecture and the genomic landscape of disease has increased exponentially. Combined with these insights, advances in analytical methods for quantifying metabolites and systems approaches to analyze these data now provide powerful tools to study metabolic regulation. Here we review the diverse mechanisms cells use to adapt metabolism to specific physiological states and discuss how metabolic flux analyses can be applied to identify important regulatory nodes to understand normal and pathological cell physiology.

Full-text preview

Available from:
  • Source
    • "Mitochondria are known to associate with the Spitzenkörper structure, a cluster of vesicles that carry enzymes and wall precursors to the active growing tips of hyphae in Neurospora crassa, Candida albicans , and other fungi[18]. The coupling of ATP synthesis to cell wall polysaccharide biosynthesis in fungi must be synchronized through signal pathways such as the S. cerevisiae AMPactivated protein kinase pathway (AMPK), which monitors the intracellular ATP/ADP ratio and apparently links energy production with wall synthesis19202122. The regulation of these events is minimally studied in fungal pathogens. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Goa1p of Candida albicans regulates mitochondrial Complex I (CI) activities in its role as a putative CI accessory protein. Transcriptional profiling of goa1∆ revealed a down regulation of genes encoding β-oligomannosyl transferases. Herein, we present data on cell wall phenotypes of goa1∆ (strain GOA31). We used transmission electron microscopy (TEM), GPC/MALLS, and NMR to compare GOA31 to a gene-reconstituted strain (GOA32) and parental cells. We note by TEM a reduction in outer wall fibrils, increased inner wall transparency, and the loss of a defined wall layer close to the plasma membrane. GPC-MALLS revealed a reduction in high and intermediate Mw mannan by 85% in GOA31. A reduction of β-mannosyl but not α-mannosyl linkages was noted in GOA31 cells. β-(1,6)-linked glucan side chains were branched about twice as often but were shorter in length for GOA31. We conclude that mitochondrial CI energy production is highly integrated with cell wall formation. Our data also suggest that not all cell wall biosynthetic processes are dependent upon Goa1p even though it provides high levels of ATP to cells. The availability of both broadly conserved and fungal-specific mutants lacking CI subunit proteins should be useful in assessing functions of fungal-specific functions subunit proteins.
    Full-text · Article · Jan 2016 · PLoS ONE
  • Source
    • "additional oncogenic mutations, tumor microenvironment). Lactate dehydrogenase A (LDHA) is commonly upregulated in cancer cells downstream of HIF1α and Myc signaling (Kim et al., 2007; Dang et al., 2008; Cairns et al., 2011); this enzyme helps maintain glycolysis via NAD+ regeneration (Metallo & Vander Heiden, 2013). One recent study observed that IDH mutant gliomas and tumor-derived brain tumor stem cells silence LDHA expression through promoter hypermethylation (Chesnelong et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Specific point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) occur in a variety of cancers, including acute myeloid leukemia (AML), low-grade gliomas, and chondrosarcomas. These mutations inactivate wild-type enzymatic activity and convey neomorphic function to produce D-2-hydroxyglutarate (D-2HG), which accumulates at millimolar levels within tumors. D-2HG can impact α-ketoglutarate-dependent dioxygenase activity and subsequently affect various cellular functions in these cancers. Inhibitors of the neomorphic activity of mutant IDH1 and IDH2 are currently in Phase I/II clinical trials for both solid and blood tumors. As IDH1 and IDH2 represent key enzymes within the tricarboxylic acid (TCA) cycle, mutations have significant impact on intermediary metabolism. The loss of some wild-type metabolic activity is an important, potentially deleterious and therapeutically exploitable consequence of oncogenic IDH mutations and requires continued investigation in the future. Here we review how IDH1 and IDH2 mutations influence cellular metabolism, epigenetics, and other biochemical functions, discussing these changes in the context of current efforts to therapeutically target cancers bearing these mutations. Copyright © 2015. Published by Elsevier Inc.
    Full-text · Article · May 2015 · Pharmacology [?] Therapeutics
  • Source
    • "Please cite this article in press as: Vacanti et al., Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier, Molecular Cell (2014), http:// (Figure 2F) (Le et al., 2012; Metallo and Vander Heiden, 2013). In the glutaminolysis pathway, glutamine is oxidized in the mitochondria and converted to pyruvate via malic enzymes (MEs). "

    Full-text · Article · Nov 2014 · Molecular cell
Show more